In earlier posts we have explored how mHealth can increase both patient engagement and site engagement. Today’s blog comes from Jason Rightmyer, Director of Research Informatics with the Institute of Aging Research (a Harvard Medical School Affiliate) who explores how mobile health technology is attributing to physician engagement. Thanks for contributing!
BBK Worldwide is once again looking forward to attending Drug Information Association 2015 (DIA), which this year will take place from June 15 - 18 at the Walter E. Washington Convention Center in DC. We always love attending this annual event – the industry’s largest, which attracts more than 7,000 attendees each year. DIA provides a global, unbiased platform to raise the level of discussion to facilitate innovation that will change the future of healthcare.
Devices like mobile phones and smartwatches are giving patients a new platform to contribute powerful, real-time data to medical researchers, but how do we make sure their contributions are truly heard and used to impact clinical research? Lily Cappelletti, Director of Research Engagement with The Michael J. Fox Foundation for Parkinson’s Research (MJFF), is today’s blog contributor. Read on to learn more about how her organization is utilizing mHealth to empower patients to make a difference through their own data and feedback.
Following last week’s successful mHealth + Patient Engagement webinar, which featured Larry Suarez, mobile architect with Oracle’s Health Sciences Global Business Unit and Daniel Bender, product manager with Empatica, we are excited to offer our latest Focus 5 eBook – a compilation of industry expert insights on the ways in which mobile health technology impacts clinical trials, raises the patient voice, and enables a higher standard of care.
Mobile devices and apps which monitor vital signs, analyze blood, and track medication adherence, among other things are quickly becoming the new norm in healthcare. But how is mHealth making its mark on clinical trials? A recent survey conducted by Applied Clinical Trials and SCORR Marketing confirms that mobile health technology is in fact poised to improve data collection and quality, and drive efficiencies across the clinical trial landscape.
We’re incredibly proud to have our My Protocol Pal (SM) mobile app and site engagement platform featured in PharmaVOICE’s inaugural Innovation issue, out today. Designed to recognize organizations that are breaking new ground, the issue celebrates “the culture of innovation and achievement across the global healthcare/pharmaceutical industry spectrum.
For patient recruitment and engagement in clinical trials, mHealth is a minimum requirement to reach and connect with patients in today’s mobile-centric world. BBK Worldwide is excited to host a panel discussion with experts from Oracle and health wearables start-up Empatica on Thursday, April 16th at 2:00pm EST where panelists will highlight real-world examples that successfully blend technology with patient centricity – the right combination that drives mHealth delivery from theory to reality.
BBK Worldwide is pleased to offer our first “Focus 5”, a compilation of quick tips, advice and insights to help companies understand patient centricity as it relates to enhanced patient recruitment and patient engagement within clinical trials.
BBK Worldwide is excited to participate in Cambridge Healthtech Institute’s annual SCOPE Summit for Clinical Ops Executives. Taking place February 24-26th in Orlando, FL, SCOPE will offer in depth discussions focused on issues related to each aspect of clinical trial planning and management, including: data integration, feasibility, site selection and management, patient engagement, recruitment and retention, mobile tech, project management, forecasting, quality (QbD) in trial conduct, risk-based monitoring, post-marketing studies, and pharmacovigilance.
This week's blog comes from our friend Christel Aprigliano of thepefectd.com. Thank you for contributing!